Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Protective treatments and their target retinal ganglion cells in diabetic retinopathy

Photobiomodulation (PBM) may be used as adjunctive therapy in protective treatment of RGCs. In this review, we highlight and discuss protective treatments and their targets which have shown great promise for treatment of RGC injury in DR.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review discusses protective treatments aimed at retinal ganglion cells in diabetic retinopathy, a diabetes complication that can cause severe vision loss. The authors report that retinal ganglion cell injury may occur before microvascular damage and that photobiomodulation may be used as an adjunctive therapy. The abstract describes the review's focus on treatment targets rather than reporting new patient results.

Who or what was studied
unclear
Limits stated in the abstract
The abstract does not report the number of studies reviewed or any specific photobiomodulation wavelengths or outcome data.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Oxidative stress. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies